fda food and drug administration

FDA, Ozempic and shortage

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.

MarketWatch · 9h

FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

CNN on MSN · 9h

Ozempic and Wegovy are no longer in shortage, FDA says

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

FDA, weight loss and Utah Attorney General

Hosted on MSN · 7h

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday.

deseret · 2h

Utah’s attorney general targets safety issues over weight loss drugs

Utah’s Attorney General Derek Brown signed onto a letter along with attorneys general from 37 other states to ask the Food and Drug Administration to enforce the safety of weight loss drugs. The letter asks the FDA to “ramp up enforcement against any compounding pharmacies that may be illegally participating in the market,

Seeking Alpha on MSN · 13h

U.S. attorneys general forum urges FDA to act against counterfeit weight loss drugs

A bipartisan group of U.S. state and territory attorneys general is pressing the FDA to take prompt action against those threatening public health by marketing counterfeit forms of branded weight loss medications developed by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY).

Mirum, FDA and Pharmaceuticals

Reuters on MSN · 7h

US FDA approves Mirum Pharma's genetic disorder drug

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first treatment for a rare condition that interferes with the body's ability to process cholesterol.

MarketWatch · 10h

FDA Approves Mirum Pharmaceuticals Treatment for Lipid-Storage Disease

The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first FDA-approved drug to treat CTX,

Business Insider · 10h

FDA approves Mirum treatment for cerebrotendinous xanthomatosis

The Food and Drug Administration approved Ctexli for the treatment of cerebrotendinous xanthomatosis in adults. “Ctexli is the first

Fierce Healthcare7h

FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market

The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...

12hon MSN

Snacks Recalled in 35 States as FDA Issues Warning

ZB Importing LLC has issued a recall for six varieties of Ülker snack rolls, biscuits and wafers due to undeclared wheat, ...

FDA Food Division Leader Quits After Staff Layoffs

Jim Jones, a deputy commissioner at the U.S. Food and Drug Administration, resigned Monday following what he called the ...

ABC Columbia38m

FDA: Ozempic, Wegovy shortage over

Feb. 21, the Food and Drug Administration said there is no longer a short supply of the weight loss and diabetes drugs Wegovy ...

5don MSN

Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products

The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...

7hon MSN

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

JD Supra9h

Make Food “Healthy” Again: FDA’s Resolution for a Healthier 2025

The U.S. Food and Drug Administration (FDA) began 2025 with a resolution to make food “healthy” again by announcing a trio of new final and ...

3don MSN

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

Key Takeaways Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results